MoneyWorks4Me

Kopran approves appointment of independent director

13 Feb 2013 Evaluate
Kopran has informed that the board of directors of the company at its meeting held on February 12, 2013, has approved the appointment of V. K. Bhandari as an independent director of the company with effect from February 12, 2013 and renewal of the appointment of Ajit Jain as whole time director of the company for further period of 3 years with effect from February 01, 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..